The Continuous Subcutaneous Insulin Infusion Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Patch Pumps), By Patient Type (Type 1 diabetes, Type 2 diabetes), By End-user (Hospitals, Homecare, Laboratory).
The continuous subcutaneous insulin infusion (CSII) market in 2024 serves the demand for insulin delivery systems used in the management of diabetes mellitus, providing continuous and customizable insulin therapy to individuals with type 1 diabetes and some patients with type 2 diabetes. Continuous subcutaneous insulin infusion pumps deliver rapid-acting insulin analogs through subcutaneous cannulas, mimicking the physiological insulin secretion pattern and offering greater flexibility in insulin dosing and mealtime coverage compared to multiple daily injections. Market dynamics are driven by factors such as the increasing prevalence of diabetes, the demand for personalized insulin therapy regimens, and advancements in insulin pump technology for improved accuracy and usability. Collaboration between medical device manufacturers, endocrinologists, and diabetes educators drives innovation and market growth in continuous subcutaneous insulin infusion, supporting optimized glycemic control and quality of life for individuals living with diabetes.
A prominent trend in the Continuous Subcutaneous Insulin Infusion market is the increasing adoption of closed-loop insulin delivery systems, also known as artificial pancreas systems. These systems combine continuous glucose monitoring (CGM) technology with insulin infusion pumps to automatically adjust insulin delivery based on real-time glucose levels. As the demand for more precise and automated insulin delivery solutions grows, closed-loop systems offer enhanced glycemic control, reduced hypoglycemic events, and improved quality of life for individuals with diabetes. The integration of advanced algorithms and sensor technologies into insulin infusion pumps reflects the ongoing trend towards personalized and technology-driven diabetes management.
A key driver for the Continuous Subcutaneous Insulin Infusion market is the rising incidence of diabetes worldwide and the increasing focus on diabetes management. With the global prevalence of diabetes continuing to rise, there's a growing need for effective insulin delivery solutions that can help individuals with diabetes achieve optimal glycemic control while minimizing the risk of complications. Continuous subcutaneous insulin infusion therapy offers several advantages over conventional insulin injection methods, including more precise dosing, flexible insulin delivery schedules, and improved adherence to treatment regimens. The emphasis on proactive diabetes management and the pursuit of better patient outcomes drive the adoption of continuous subcutaneous insulin infusion therapy as a cornerstone of modern diabetes care.
An opportunity for the Continuous Subcutaneous Insulin Infusion market lies in the expansion into emerging markets. While the adoption of insulin pump therapy is relatively high in developed regions, such as North America and Europe, there's untapped potential for growth in emerging markets across Asia-Pacific, Latin America, and the Middle East. Factors such as increasing disposable income, improving healthcare infrastructure, and rising awareness of diabetes management contribute to the growing demand for advanced insulin delivery solutions in these regions. Manufacturers can capitalize on this opportunity by introducing affordable and user-friendly insulin infusion pumps tailored to the needs of emerging market populations. By expanding their presence in emerging markets, companies can broaden their customer base, address unmet medical needs, and contribute to improving diabetes care on a global scale.
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Cellenovo
CeQur
F Hoffmann-La Roche
Insulet Corp
Medtronic Inc
Sooil Development
Tandem Diabetes Care
Valeritas Inc
Ypsomed
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Continuous Subcutaneous Insulin Infusion Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Continuous Subcutaneous Insulin Infusion Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Continuous Subcutaneous Insulin Infusion Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Continuous Subcutaneous Insulin Infusion Market Size Outlook, $ Million, 2021 to 2030
3.2 Continuous Subcutaneous Insulin Infusion Market Outlook By Type, $ Million, 2021 to 2030
3.3 Continuous Subcutaneous Insulin Infusion Market Outlook By Product, $ Million, 2021 to 2030
3.4 Continuous Subcutaneous Insulin Infusion Market Outlook By Application, $ Million, 2021 to 2030
3.5 Continuous Subcutaneous Insulin Infusion Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Continuous Subcutaneous Insulin Infusion Market Industry
4.2 Key Market Trends in Continuous Subcutaneous Insulin Infusion Market Industry
4.3 Potential Opportunities in Continuous Subcutaneous Insulin Infusion Market Industry
4.4 Key Challenges in Continuous Subcutaneous Insulin Infusion Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Continuous Subcutaneous Insulin Infusion Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Continuous Subcutaneous Insulin Infusion Market Outlook By Segments
7.1 Continuous Subcutaneous Insulin Infusion Market Outlook by Segments
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
8 North America Continuous Subcutaneous Insulin Infusion Market Analysis And Outlook To 2030
8.1 Introduction to North America Continuous Subcutaneous Insulin Infusion Markets in 2024
8.2 North America Continuous Subcutaneous Insulin Infusion Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Continuous Subcutaneous Insulin Infusion Market size Outlook by Segments, 2021-2030
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
9 Europe Continuous Subcutaneous Insulin Infusion Market Analysis And Outlook To 2030
9.1 Introduction to Europe Continuous Subcutaneous Insulin Infusion Markets in 2024
9.2 Europe Continuous Subcutaneous Insulin Infusion Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Continuous Subcutaneous Insulin Infusion Market Size Outlook By Segments, 2021-2030
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
10 Asia Pacific Continuous Subcutaneous Insulin Infusion Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Continuous Subcutaneous Insulin Infusion Markets in 2024
10.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Continuous Subcutaneous Insulin Infusion Market size Outlook by Segments, 2021-2030
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
11 South America Continuous Subcutaneous Insulin Infusion Market Analysis And Outlook To 2030
11.1 Introduction to South America Continuous Subcutaneous Insulin Infusion Markets in 2024
11.2 South America Continuous Subcutaneous Insulin Infusion Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Continuous Subcutaneous Insulin Infusion Market size Outlook by Segments, 2021-2030
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
12 Middle East And Africa Continuous Subcutaneous Insulin Infusion Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Continuous Subcutaneous Insulin Infusion Markets in 2024
12.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Continuous Subcutaneous Insulin Infusion Market size Outlook by Segments, 2021-2030
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Cellenovo
CeQur
F Hoffmann-La Roche
Insulet Corp
Medtronic Inc
Sooil Development
Tandem Diabetes Care
Valeritas Inc
Ypsomed
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Patch Pumps
-Basal
-Bous
-Basal and bolus
Tethered pumps
-Insulin reservoir and cartridges
-Insulin set insertion devices
-Battery
By Patient Type
Type 1 diabetes
Type 2 diabetes
By End-user
Hospitals
Homecare
Laboratory
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Continuous Subcutaneous Insulin Infusion Market is one of the lucrative growth markets, poised to register a 10.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Cellenovo, CeQur, F Hoffmann-La Roche, Insulet Corp, Medtronic Inc, Sooil Development, Tandem Diabetes Care, Valeritas Inc, Ypsomed
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume